GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Primo Nutraceuticals Inc (OTCPK:BUGVF) » Definitions » Enterprise Value

Primo Nutraceuticals (Primo Nutraceuticals) Enterprise Value : $0.00 Mil (As of May. 27, 2024)


View and export this data going back to 2019. Start your Free Trial

What is Primo Nutraceuticals Enterprise Value?

Think of Enterprise Value as the theoretical takeover price. It is more comprehensive than market capitalization (Market Cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash, cash equivalents, and marketable securities.

EV-to-EBIT is calculated as Enterprise Value divided by its EBIT. As of today, Primo Nutraceuticals's Enterprise Value is $0.00 Mil. Primo Nutraceuticals's EBIT for the trailing twelve months (TTM) ended in Apr. 2020 was $-1.13 Mil. Therefore, Primo Nutraceuticals's EV-to-EBIT ratio for today is 0.00.

EV-to-EBITDA is calculated as Enterprise Value divided by its EBITDA. As of today, Primo Nutraceuticals's Enterprise Value is $0.00 Mil. Primo Nutraceuticals's EBITDA for the trailing twelve months (TTM) ended in Apr. 2020 was $-1.13 Mil. Therefore, Primo Nutraceuticals's EV-to-EBITDA ratio for today is 0.00.

EV-to-Revenue is calculated as Enterprise Value divided by its Revenue. As of today, Primo Nutraceuticals's Enterprise Value is $0.00 Mil. Primo Nutraceuticals's Revenue for the trailing twelve months (TTM) ended in Apr. 2020 was $0.00 Mil. Therefore, Primo Nutraceuticals's EV-to-Revenue ratio for today is .


Primo Nutraceuticals Enterprise Value Historical Data

The historical data trend for Primo Nutraceuticals's Enterprise Value can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Primo Nutraceuticals Enterprise Value Chart

Primo Nutraceuticals Annual Data
Trend Jul16 Jul17 Jul18 Jul19
Enterprise Value
- - - 7.28

Primo Nutraceuticals Quarterly Data
Jul16 Oct16 Jan17 Apr17 Jul17 Oct17 Jan18 Apr18 Jul18 Oct18 Jan19 Apr19 Jul19 Oct19 Jan20 Apr20
Enterprise Value Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 4.94 7.28 10.97 11.15 1.94

Competitive Comparison of Primo Nutraceuticals's Enterprise Value

For the Drug Manufacturers - Specialty & Generic subindustry, Primo Nutraceuticals's Enterprise Value, along with its competitors' market caps and Enterprise Value data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Primo Nutraceuticals's Enterprise Value Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Primo Nutraceuticals's Enterprise Value distribution charts can be found below:

* The bar in red indicates where Primo Nutraceuticals's Enterprise Value falls into.



Primo Nutraceuticals Enterprise Value Calculation

Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash, cash equivalents, and marketable securities.

Primo Nutraceuticals's Enterprise Value for the fiscal year that ended in Jul. 2019 is calculated as

Primo Nutraceuticals's Enterprise Value for the quarter that ended in Apr. 2020 is calculated as

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Primo Nutraceuticals  (OTCPK:BUGVF) Enterprise Value Explanation

When an investor buy a company, the investor needs to pay not only the common shares, he/she also needs to pay the shareholders of Preferred Stocks. He also assumes the debt of the company, and receives the cash on the company's balance sheet.

If a company has more cash than debt, the investor actually pays less than the Market Cap because he immediately owns the cash once the transaction goes through.

The market value of Preferred Stock needs to be added to the market value of common stocks in the calculation of Enterprise Value.

For the companies with the same Market Cap, the smaller the Enterprise Value is, the cheaper the company is.

Enterprise Value can be negative when the company's net cash is more than its Market Cap. In this case the investor is basically getting the company for free and get paid for that.

1. EV-to-EBIT is calculated as Enterprise Value divided by its EBIT.

Primo Nutraceuticals's EV-to-EBIT for today is

EV-to-EBIT=Enterprise Value (Today)/EBIT (TTM)
=0.000/-1.127
=0.00

Primo Nutraceuticals's current Enterprise Value is $0.00 Mil.
Primo Nutraceuticals's EBIT for the trailing twelve months (TTM) ended in Apr. 2020 adds up the quarterly data reported by the company within the most recent 12 months, which was $-1.13 Mil.

2. EV-to-EBITDA is calculated as Enterprise Value divided by its EBITDA.

Primo Nutraceuticals's EV-to-EBITDA for today is:

EV-to-EBITDA=Enterprise Value (Today)/EBITDA(TTM)
=0.000/-1.127
=0.00

Primo Nutraceuticals's current Enterprise Value is $0.00 Mil.
Primo Nutraceuticals's EBITDA for the trailing twelve months (TTM) ended in Apr. 2020 adds up the quarterly data reported by the company within the most recent 12 months, which was $-1.13 Mil.

3. EV-to-Revenue is calculated as Enterprise Value divided by its Revenue.

Primo Nutraceuticals's EV-to-Revenue for today is:

EV-to-Revenue=Enterprise Value (Today)/Revenue (TTM)
=0.000/0
=

Primo Nutraceuticals's current Enterprise Value is $0.00 Mil.
Primo Nutraceuticals's Revenue for the trailing twelve months (TTM) ended in Apr. 2020 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.00 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Primo Nutraceuticals Enterprise Value Related Terms

Thank you for viewing the detailed overview of Primo Nutraceuticals's Enterprise Value provided by GuruFocus.com. Please click on the following links to see related term pages.


Primo Nutraceuticals (Primo Nutraceuticals) Business Description

Traded in Other Exchanges
N/A
Address
890 West Pender Street, Suite 440, Vancouver, BC, CAN, V6C 1J9
Primo Nutraceuticals Inc is engaged in the production, processing, retail and branding of cannabis and cannabis-related products. The company offer fully built out turnkey facilities equipped with state-of-the-art growing infrastructure to cannabis growers and processors.